What is ERLEADA®?
ERLEADA® is a prescription medicine used to treat two types of prostate cancer:
Prostate cancer that HAS SPREAD to other parts of the body and STILL responds to a medical or surgical treatment that lowers testosterone.
This is called metastatic castration-sensitive prostate cancer, or mCSPC.
OR
Prostate cancer that HAS NOT SPREAD to other parts of the body and NO LONGER responds to a medical or surgical treatment that lowers testosterone.
This is called non-metastatic castration-resistant prostate cancer, or nmCRPC.
How may ERLEADA® help you?
The short quiz below can help you find specific information about prostate cancer and ERLEADA®.
Please select the options that best describe your interest:
- 1
- 2
- 3
- I’m currently taking ERLEADA®
- I’m currently on another treatment
- I don’t know what kind of prostate cancer I have
Personalized Support. From People Who Care.
Your personal Care Navigator is just a phone call away.
You can also call us at 844-NAV-1234 (844-628-1234),
Monday through Friday, 8:30 AM - 8:30 PM ET
Patient Support from Janssen Compass™
Janssen Compass™ is limited to education for patients about their Janssen therapy, its administration, and/or their disease. It is intended to supplement a patient’s understanding of their therapy and is not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe this medication.